AUG 01, 2020 11:27 PM PDT

Harnessing The Power of Synthetic Lethality

WRITTEN BY: Nouran Amin

Studies into genome sequencing has pushed researchers to harness the power of "synthetic lethality" in exploiting cancer-specific genetic defects and eventually identify therapeutic targets.  

Scientists at San Diego branch of Ludwig Institute for Cancer Research and University of California San Diego School of Medicine have observed that inhibition of a critical enzyme in cancer cells led to reduced tumor growth. These findings were examined in mouse models of breast and ovarian cancer. 

Results were reported in the Proceedings of the National Academy of Sciences (PNAS) and describe synthetic lethality is a result of non-lethal mutations become fatal when combined in cells. One model organism for this phenomenon is species of yeast, Saccharomyces cerevisiae, that provides an excellent genetic tool for synthetic lethal relationships. 

Learn more about synthetic lethality: 

 

Using these model organisms, researchers were able to pinpoint an enzyme referred to as Flap Endonuclease 1 (FEN1). The DNA structure-specific endonuclease is involved in repairing and replicating DNA. Specifically, blocking their function in cancer cells and will ultimately inhibit tumor growth. 

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 23, 2020
Cardiology
Protecting the Heart After a Heart Attack
JUL 23, 2020
Protecting the Heart After a Heart Attack
Cardiovascular disease accounts for thirty percent of mortalities around the world. These diseases start small and slowl ...
JUL 21, 2020
Health & Medicine
FDA Produces Draft Guidelines on Developing Cannabis Drugs
JUL 21, 2020
FDA Produces Draft Guidelines on Developing Cannabis Drugs
The FDA’s Center for Drug Evaluation and Research has produced guidelines for research into cannabis-related ingre ...
JUL 29, 2020
Health & Medicine
The Carrier Oil Matters When it Comes to CBD Products
JUL 29, 2020
The Carrier Oil Matters When it Comes to CBD Products
The type of oil that is used to extract and carry the medicinally active ingredients (cannabinoids and terpenes) in cann ...
AUG 05, 2020
Drug Discovery & Development
New Drug Prevents Inherited Alzheimer's in Mice
AUG 05, 2020
New Drug Prevents Inherited Alzheimer's in Mice
Researchers at the Salk Institute have developed a new drug candidate that has successfully prevented Alzheimer's-re ...
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 13, 2020
Drug Discovery & Development
Scientists Find Way to Reduce Inflammation from Vaccines
SEP 13, 2020
Scientists Find Way to Reduce Inflammation from Vaccines
Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a ...
Loading Comments...